Christina Franssen
Directeur/Membre du Conseil chez Novadip Biosciences SA
Profil
Christina Franssen is currently a Director at ImCyse SA, Novadip Biosciences SA, Exothera SA, THERAtRAME SA, and an Investment Manager at Société Régionale d'Investissement de Wallonie SA. She previously worked as a Managing Director at DNAVision Agrifood SA and a General Manager at DNAVision NV.
Dr. Franssen holds a doctorate degree from the University of Liege.
Postes actifs de Christina Franssen
Sociétés | Poste | Début |
---|---|---|
Société Régionale d'Investissement de Wallonie SA
Société Régionale d'Investissement de Wallonie SA Investment ManagersFinance Société Régionale d'Investissement de Wallonie SA (SRIW) is a private equity & venture capital firm , a subsidiary of Region of Wallonia founded in 1979. Société Régionale d'Investissement de Wallonie SA is headquartered in Liege, Belgium. | Private Equity Investor | 01/01/2019 |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Directeur/Membre du Conseil | 01/01/2019 |
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | Directeur/Membre du Conseil | - |
Exothera SA
Exothera SA Chemicals: SpecialtyProcess Industries Exothera SA is a Belgian company that manufactures and develops viral vector and nucleic acid. The private company is based in Jumet, Belgium. The company was founded in 2020 by José Fernandez Castillo, Hugues Bultot. The CEO is Thibault Jonckheere. | Directeur/Membre du Conseil | - |
THERAtRAME SA
THERAtRAME SA BiotechnologyHealth Technology THERAtRAME SA is a drug discovery start-up company based in Liege, Belgium. The Belgian company aims to become a leader in the development and positioning of novel cancer therapies by exploring new target areas to develop innovative cancer therapies. THERAtRAME's discovery platform integrates unique sets of technologies to discover, develop, and position new drugs to beat reluctant cancers. The company exploits the latest scientific discoveries highlighting the unexpected importance of trna epitranscriptomics dynamics in cancer. THERAtRAME is looking for a drug discovery assay developer leader to join their team. The company was founded by Francesca Rapino, Pierre Close, and has a team of experienced professionals with backgrounds in life sciences, medico-marketing, and biotech venture creations. | Directeur/Membre du Conseil | 01/01/2022 |
Anciens postes connus de Christina Franssen
Sociétés | Poste | Fin |
---|---|---|
DNAVision Agrifood SA
DNAVision Agrifood SA BiotechnologyHealth Technology DNAVision Agrifood SA provides genetic services and products to the pharmaceutical, food, and biotechnology industries. It offers the combination of different technologies in nucleic acids extraction, expression profiling, SNP genotyping and sequencing in environment. The company was founded in 2008 and is headquartered in Liege, Belgium. | President | 01/08/2012 |
DNAVision NV
DNAVision NV BiotechnologyHealth Technology DNAVision SA operates as a research and development company. The firm provides genomic services to the pharmaceutical, food and biotechnology industries. It offers Non-Executive Directortgen seqencing, bioinformatics, sanger sequence, expression profiling, DNA extraction and biobanking. The company was founded in May 2004 and is headquartered in Charleroi, Belgium. | Corporate Officer/Principal | - |
Formation de Christina Franssen
University of Liege | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 7 |
---|---|
Société Régionale d'Investissement de Wallonie SA
Société Régionale d'Investissement de Wallonie SA Investment ManagersFinance Société Régionale d'Investissement de Wallonie SA (SRIW) is a private equity & venture capital firm , a subsidiary of Region of Wallonia founded in 1979. Société Régionale d'Investissement de Wallonie SA is headquartered in Liege, Belgium. | Finance |
DNAVision NV
DNAVision NV BiotechnologyHealth Technology DNAVision SA operates as a research and development company. The firm provides genomic services to the pharmaceutical, food and biotechnology industries. It offers Non-Executive Directortgen seqencing, bioinformatics, sanger sequence, expression profiling, DNA extraction and biobanking. The company was founded in May 2004 and is headquartered in Charleroi, Belgium. | Health Technology |
DNAVision Agrifood SA
DNAVision Agrifood SA BiotechnologyHealth Technology DNAVision Agrifood SA provides genetic services and products to the pharmaceutical, food, and biotechnology industries. It offers the combination of different technologies in nucleic acids extraction, expression profiling, SNP genotyping and sequencing in environment. The company was founded in 2008 and is headquartered in Liege, Belgium. | Health Technology |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Health Technology |
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | Health Technology |
Exothera SA
Exothera SA Chemicals: SpecialtyProcess Industries Exothera SA is a Belgian company that manufactures and develops viral vector and nucleic acid. The private company is based in Jumet, Belgium. The company was founded in 2020 by José Fernandez Castillo, Hugues Bultot. The CEO is Thibault Jonckheere. | Process Industries |
THERAtRAME SA
THERAtRAME SA BiotechnologyHealth Technology THERAtRAME SA is a drug discovery start-up company based in Liege, Belgium. The Belgian company aims to become a leader in the development and positioning of novel cancer therapies by exploring new target areas to develop innovative cancer therapies. THERAtRAME's discovery platform integrates unique sets of technologies to discover, develop, and position new drugs to beat reluctant cancers. The company exploits the latest scientific discoveries highlighting the unexpected importance of trna epitranscriptomics dynamics in cancer. THERAtRAME is looking for a drug discovery assay developer leader to join their team. The company was founded by Francesca Rapino, Pierre Close, and has a team of experienced professionals with backgrounds in life sciences, medico-marketing, and biotech venture creations. | Health Technology |